John G Ullman & Associates Inc Pfizer Inc Transaction History

John G Ullman & Associates Inc

$649 Million
Q3 2024

A detailed history of John G Ullman & Associates Inc transactions in Pfizer Inc stock. As of the latest transaction made, John G Ullman & Associates Inc holds 337,323 shares of PFE stock, worth $8.65 Million. This represents 1.51% of its overall portfolio holdings.

Number of Shares

337,323

Previous 343,265 1.73%

Holding current value

$8.65 Million

Previous $9.6 Million 1.65%

% of portfolio

1.51%

Previous 1.52%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$27.7 - $31.39 $164,593 - $186,519	-5,942 Reduced 1.73%	337,323 $9.76 Million
Q2 2024 Aug 08, 2024	SELL	$25.26 - $29.6 $237,595 - $278,417	-9,406 Reduced 2.67%	343,265 $9.6 Million
Q1 2024 May 06, 2024	SELL	$25.89 - $29.73 $1.42 Million - $1.64 Million	-55,037 Reduced 13.5%	352,671 $9.79 Million
Q4 2023 Jan 31, 2024	SELL	$26.13 - $33.94 $4.42 Million - $5.74 Million	-169,128 Reduced 29.32%	407,708 $11.7 Million
Q3 2023 Nov 01, 2023	SELL	$32.09 - $37.51 $580,668 - $678,743	-18,095 Reduced 3.04%	576,836 $19.1 Million
Q2 2023 Aug 21, 2023	BUY	$36.12 - $41.79 $87,049 - $100,713	2,410 Added 0.41%	594,931 $21.8 Million
Q1 2023 May 05, 2023	SELL	$39.39 - $51.28 $589,628 - $767,610	-14,969 Reduced 2.46%	592,521 $24.2 Million
Q4 2022 Feb 08, 2023	SELL	$41.75 - $54.5 $361,137 - $471,425	-8,650 Reduced 1.4%	607,490 $31.1 Million
Q3 2022 Oct 19, 2022	SELL	$43.76 - $53.42 $284,440 - $347,230	-6,500 Reduced 1.04%	616,140 $27 Million
Q2 2022 Jul 27, 2022	SELL	$46.53 - $55.17 $158,248 - $187,633	-3,401 Reduced 0.54%	622,640 $32.6 Million
Q1 2022 Apr 29, 2022	SELL	$45.75 - $56.69 $417,514 - $517,352	-9,126 Reduced 1.44%	626,041 $32.4 Million
Q4 2021 Jan 26, 2022	SELL	$41.32 - $61.25 $342,253 - $507,333	-8,283 Reduced 1.29%	635,167 $37.5 Million
Q3 2021 Nov 02, 2021	SELL	$39.25 - $50.42 $398,897 - $512,418	-10,163 Reduced 1.55%	643,450 $27.7 Million
Q2 2021 Jul 23, 2021	BUY	$35.91 - $40.68 $175,456 - $198,762	4,886 Added 0.75%	653,613 $25.6 Million
Q1 2021 Apr 22, 2021	BUY	$33.49 - $37.77 $1.39 Million - $1.56 Million	41,416 Added 6.82%	648,727 $23.5 Million
Q4 2020 Feb 05, 2021	BUY	$33.47 - $42.56 $1.94 Million - $2.47 Million	57,985 Added 10.56%	607,311 $22.4 Million
Q3 2020 Nov 06, 2020	BUY	$31.75 - $37.25 $348,202 - $408,520	10,967 Added 2.04%	549,326 $20.2 Million
Q2 2020 Jul 29, 2020	BUY	$30.12 - $36.54 $53,944 - $65,443	1,791 Added 0.33%	538,359 $17.6 Million
Q1 2020 Apr 14, 2020	BUY	$27.03 - $38.62 $1.31 Million - $1.88 Million	48,601 Added 9.96%	536,568 $17.5 Million
Q4 2019 Jan 29, 2020	BUY	$32.92 - $37.36 $908,394 - $1.03 Million	27,594 Added 5.99%	487,967 $19.1 Million
Q3 2019 Oct 21, 2019	BUY	$32.49 - $42.13 $798,116 - $1.03 Million	24,565 Added 5.64%	460,373 $16.5 Million
Q2 2019 Aug 02, 2019	SELL	$36.98 - $41.52 $113,528 - $127,466	-3,070 Reduced 0.7%	435,808 $18.9 Million
Q1 2019 Apr 30, 2019	SELL	$37.5 - $41.2 $217,275 - $238,712	-5,794 Reduced 1.3%	438,878 $18.6 Million
Q4 2018 Jan 29, 2019	SELL	$38.47 - $43.86 $160,535 - $183,027	-4,173 Reduced 0.93%	444,672 $19.4 Million
Q3 2018 Nov 02, 2018	BUY	$34.47 - $41.81 $5,653 - $6,856	164 Added 0.04%	448,845 $19.8 Million
Q2 2018 Jul 23, 2018	SELL	$32.98 - $35.16 $236,169 - $251,780	-7,161 Reduced 1.57%	448,681 $16.3 Million
Q1 2018 Apr 19, 2018	BUY	$31.91 - $37.02 $74,669 - $86,626	2,340 Added 0.52%	455,842 $16.2 Million
Q4 2017 Jan 31, 2018	SELL	$33.26 - $35.29 $242,365 - $257,158	-7,287 Reduced 1.58%	453,502 $16.4 Million
Q3 2017 Nov 03, 2017	BUY	$31.0 - $34.15 $14.3 Million - $15.7 Million	460,789	460,789 $16.5 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of John G Ullman & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on John G Ullman & Associates Inc with notifications on news.

Account

John G Ullman & Associates Inc Pfizer Inc Transaction History